8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jul 21, 2009)

Filed July 21, 2009For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on July 21, 2009, to report its financial results for the quarter ended June 30, 2009. The filing primarily consists of a press release detailing these results, which is incorporated by reference. This event is significant for investors as it provides timely updates on the company's performance and financial condition during the second quarter of 2009. While the 8-K itself does not contain the detailed financial statements, it serves as the official notification mechanism for the release of this critical information. Investors should refer to the press release (Exhibit 99.1) for specific revenue, earnings, and other operational and financial metrics that would inform their investment decisions regarding Quest Diagnostics.

Key Highlights

  • 1Quest Diagnostics filed an 8-K on July 21, 2009, reporting financial results for the quarter ended June 30, 2009.
  • 2The primary item reported is a press release detailing the company's operational and financial performance for Q2 2009.
  • 3The press release is attached as Exhibit 99.1 and is incorporated by reference into the 8-K filing.
  • 4This filing serves as the official notification of the company's quarterly earnings announcement.
  • 5Investors can find specific financial and operational details within the referenced press release.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and report Quest Diagnostics' financial results and operational performance for the fiscal quarter ended June 30, 2009. This is done by incorporating a press release issued on the same day.

The detailed financial results for the quarter ended June 30, 2009, are located in the press release filed as Exhibit 99.1 with this 8-K. This press release is incorporated by reference into the 8-K.

The 8-K filing was signed by Robert A. Hagemann, Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated.